News articles about Morgan Stanley China A Share Fund (NYSE:CAF) have trended somewhat positive this week, Accern Sentiment reports. The research group identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Morgan Stanley China A Share Fund earned a news impact score of 0.10 on Accern’s scale. Accern also gave media stories about the investment management company an impact score of 46.3453304092455 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Morgan Stanley China A Share Fund (NYSE CAF) opened at $24.20 on Monday. Morgan Stanley China A Share Fund has a 12-month low of $16.94 and a 12-month high of $24.70.

WARNING: This report was originally posted by Watch List News and is owned by of Watch List News. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://www.watchlistnews.com/morgan-stanley-china-a-share-fund-caf-given-daily-coverage-optimism-rating-of-0-10/1728759.html.

About Morgan Stanley China A Share Fund

The Morgan Stanley China A Share Fund, Inc (the Fund) is a non-diversified, closed-end management investment company. The Fund’s investment objective is to seek capital growth by investing, under normal circumstances, approximately 80% of its assets in A-shares of Chinese companies listed on the Shanghai and Shenzhen Stock Exchanges.

Insider Buying and Selling by Quarter for Morgan Stanley China A Share Fund (NYSE:CAF)

Receive News & Ratings for Morgan Stanley China A Share Fund Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley China A Share Fund Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.